Target intelligence / Profile preview

NPHP3 antisense RNA 1 (NPHP3-AS1)

Target
NPHP3-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA
01

Overview

NPHP3 antisense RNA 1 (NPHP3-AS1) is a long non-coding RNA (lncRNA) encoded in the human genome and located antisense to the NPHP3 gene on chromosome 3[1][4]. This molecule does not code for a protein but is thought to play a role in the regulation of gene expression, potentially affecting chromatin structure, RNA stability, and the transcription of neighboring genes[1][6]. NPHP3-AS1 has been implicated in various physiological and pathological processes, including kidney development and disease (notably nephronophthisis 3) as well as several cancer types[1][6][8]. Differential expression of NPHP3-AS1 and other lncRNAs in peripheral blood mononuclear cells has been identified as a possible biomarker for breast cancer and other oncological diseases[6]. Antisense RNAs such as NPHP3-AS1 may also play a regulatory role in cardiovascular and neurodegenerative disorders[6][8]. There is currently no evidence that this molecule is directly targeted pharmacologically (i.e., no interacting drugs or mechanism of action), and it is not a classical therapeutic target such as a receptor, enzyme, or transporter[1][6].

Other names
NCRNA00119NPHP3-AS1 (non-protein coding)
02

Biological functions

Gene expression regulationChromatin and genome architecture modulationRNA stabilizationTranscriptional regulation
03

Disease associations

CancerNephronophthisis 3Renal-hepatic-pancreatic dysplasia 1Atrial fibrillation-valvular heart diseaseNeurodegenerative disease (e.g., Alzheimer’s disease)
04

Biomarkers

Breast cancer (specifically luminal A subtype)oncological disorders (as indicated by changes in PBMC-derived lncRNAs)potential for use as minimally invasive biomarker

Beyond the preview

Go deeper on NPHP3 antisense RNA 1 (NPHP3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NPHP3 antisense RNA 1 (NPHP3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call